BioVaxys Technology Corp. (BIOV.CN)
CAD 0.05
(11.11%)
CAD 0.05
(11.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.48 Million CAD | 112.65% |
| 2022 | 1.63 Million CAD | 401.46% |
| 2021 | 326.86 Thousand CAD | -63.69% |
| 2020 | 900.09 Thousand CAD | 674.93% |
| 2019 | 116.15 Thousand CAD | -37.1% |
| 2018 | 184.66 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.87 Million CAD | -17.54% |
| 2024 Q3 | 2.65 Million CAD | -4.82% |
| 2024 Q2 | 2.79 Million CAD | -2.88% |
| 2023 FY | 3.48 Million CAD | 112.65% |
| 2023 Q1 | 1.87 Million CAD | 14.45% |
| 2023 Q2 | 1.75 Million CAD | -6.43% |
| 2023 Q4 | 3.48 Million CAD | 71.13% |
| 2023 Q3 | 2.03 Million CAD | 16.04% |
| 2022 Q4 | 1.63 Million CAD | -3.02% |
| 2022 FY | 1.63 Million CAD | 401.46% |
| 2022 Q3 | 1.69 Million CAD | 67.74% |
| 2022 Q2 | 1 Million CAD | 16.06% |
| 2022 Q1 | 868.18 Thousand CAD | 165.61% |
| 2021 Q3 | 292.26 Thousand CAD | -17.8% |
| 2021 Q1 | 318.9 Thousand CAD | -64.57% |
| 2021 Q2 | 355.55 Thousand CAD | 11.49% |
| 2021 FY | 326.86 Thousand CAD | -63.69% |
| 2021 Q4 | 326.86 Thousand CAD | 11.84% |
| 2020 Q4 | 900.09 Thousand CAD | 21.67% |
| 2020 FY | 900.09 Thousand CAD | 674.93% |
| 2020 Q3 | 739.79 Thousand CAD | 328.03% |
| 2020 Q2 | 172.83 Thousand CAD | 33.1% |
| 2020 Q1 | 129.85 Thousand CAD | 11.8% |
| 2019 FY | 116.15 Thousand CAD | -37.1% |
| 2019 Q3 | 91.58 Thousand CAD | -4.04% |
| 2019 Q1 | 72.32 Thousand CAD | 0.0% |
| 2019 Q2 | 95.44 Thousand CAD | 31.96% |
| 2019 Q4 | 116.15 Thousand CAD | 26.83% |
| 2018 FY | 184.66 Thousand CAD | 0.0% |
| 2018 Q3 | 35.13 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 2.71 Million CAD | -28.156% |
| Asep Medical Holdings Inc | 3.05 Million CAD | -14.21% |
| BetterLife Pharma Inc. | 8.02 Million CAD | 56.542% |
| ChitogenX Inc. | 6.71 Million CAD | 48.07% |
| Rapid Dose Therapeutics Corp. | 5.04 Million CAD | 30.885% |
| Defence Therapeutics Inc. | 4.06 Million CAD | 14.191% |
| Entheon Biomedical Corp. | 85.32 Thousand CAD | -3984.967% |
| Gemina Laboratories Ltd. | 3.04 Million CAD | -14.6% |
| Glow Lifetech Corp. | 2.34 Million CAD | -48.565% |
| Lexston Life Sciences Corp. | 39.86 Thousand CAD | -8642.479% |
| Pharmala Biotech Holdings Inc. | 1.02 Million CAD | -238.723% |
| Doseology Sciences Inc. | 82.49 Thousand CAD | -4125.305% |
| MYND Life Sciences Inc. | 5.77 Million CAD | 39.641% |
| Nova Mentis Life Science Corp. | 841.66 Thousand CAD | -314.126% |
| PharmaTher Holdings Ltd. | 252.9 Thousand CAD | -1278.223% |
| PreveCeutical Medical Inc. | 5.95 Million CAD | 41.515% |
| Telescope Innovations Corp. | 1.35 Million CAD | -157.992% |